Next Day Disclosure Return
Filed with HKEX · Stock code 6622 · · 9 pages · English
Zhaoke Ophthalmology Ltd. on 6ix
Earlier from Zhaoke Ophthalmology
- Inside information - the company's self-developed innovative drug Cyclosporine Ophthalmic Gel receives marketing approval from the national medical products administration
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Voluntary announcement - Zhaoke Ophthalmology's manufacturing facility obtains gmp certification from the therapeutic goods administration of australia ("tga")
Follow Zhaoke Ophthalmology into a list and get an email when it puts out news.
Follow Zhaoke Ophthalmology